Study guide
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications
Key Takeaways Explain This Topic AI
The spinal cord terminates at L1-L2 in adults (L3 in infants/neonates), while the dural sac and subarachnoid space terminate at S2 in adults (S3-S4 in infants). Lumbar puncture is safely performed at the L3-L4 or L4-L5 interspaces below the conus medullaris (located using Tuffier's line across the superior iliac crests).
A midline spinal traverses 8 distinct tissue layers (Skin → Subcutaneous fat → Supraspinous ligament → Interspinous ligament → Ligamentum flavum → Epidural space → Dura mater → Arachnoid mater into CSF); the paramedian approach bypasses the supraspinous and interspinous ligaments, entering directly through paraspinal muscle into the ligamentum flavum.
Local anesthetic baricity governs intrathecal spread relative to CSF density (1.0003–1.0008 g/mL): Hyperbaric solutions (in 5–8% dextrose) sink to dependent curvatures (T4 thoracic kyphosis and sacral hollow), hypobaric solutions float, and isobaric solutions remain near injection; differential blockade produces sympathetic block 2–6 dermatomes above sensory, and motor block 2 dermatomes below.
High or total spinal anesthesia causes profound sympathectomy: T1-T4 cardioaccelerator blockade produces severe bradycardia and hypotension; underfilled ventricles trigger the Bezold-Jarisch reflex (BJR). Treatment mandates 100% O₂, early airway protection, aggressive crystalloid boluses, Ephedrine/Epinephrine, and lower extremity elevation.
Cauda Equina Syndrome (CES) represents irreversible neurotoxic injury to lumbosacral roots causing permanent saddle anesthesia and bowel/bladder incontinence (historically linked to 5% lidocaine via microcatheters). Transient Neurologic Symptoms (TNS) present as self-limiting burning/aching in the buttocks/legs without neurological deficits (highest incidence with lidocaine and lithotomy position; lowest with bupivacaine).
Last updated: August 2026
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications
Spinal (subarachnoid) anesthesia involves the injection of a local anesthetic into the cerebrospinal fluid (CSF) within the lumbar subarachnoid space to produce temporary sensory, motor, and autonomic blockade. Mastery of vertebral column anatomy, meningeal architecture, baricity kinetics, differential physiological blockade, and life-threatening complications is fundamental to nurse anesthesia practice.
1. Functional Anatomy of the Vertebral Column & Spinal Canal
Safe lumbar puncture requires an exact spatial understanding of spinal cord termination, dural sac boundaries, surface landmarks, and meningeal layers. +-------------------------------------------------------------------------+
- | SPINAL CORD & DURAL SAC BOUNDARIES |
- +-----------------------+------------------------+------------------------+
- | Anatomical Structure | Adult Level | Infant / Neonate Level |
- +-----------------------+------------------------+------------------------+
- | **Conus Medullaris** | **L1 - L2** | **L3** |
- | (Cord Termination) | (Lower border L1) | (Migrates to L1 by 1 yr)|
- | **Dural Sac &** | **S2** | **S3 - S4** |
- | **Subarachnoid Space**| (Posterior sup. spine) | (Higher sacral volume) |
- | **Tuffier's Line** | **L4 Body or L4-L5** | **L5 - S1** |
- | (Intercristal line) | Interspace | (Relatively lower) |
- +-----------------------+------------------------+------------------------+
- Vertebral Surface Landmarks
C7 (Vertebra Prominens): Most prominent palpable spinous process at the base of the neck.
T3: Level of the spine of the scapula.
T7: Level of the inferior angle of the scapula.
L4 - L5 Interspace (Tuffier's / Intercristal Line): A horizontal line connecting the highest points of the iliac crests intersects the vertebral column at the L4 vertebral body or the L4-L5 interspinous space .
Lumbar Puncture Safe Zone: Subarachnoid access must always be performed at or below L3-L4 (e.g., L3-L4, L4-L5, or L5-S1) in adults to avoid direct mechanical needle trauma to the conus medullaris.
Meninges & Fluid Compartments
Dura Mater (Pachymeninx): Dense, fibroelastic outer tubular sheath extending from the foramen magnum to the S2 vertebra.
Arachnoid Mater: Avascular, delicate cellular membrane intimately pressed against the inner surface of the dura. The arachnoid represents the primary pharmacological barrier to the systemic uptake and diffusion of substances into the CSF.
Pia Mater: Thin, highly vascular membrane adherent directly to the spinal cord surface, forming the denticulate ligaments laterally and the filum terminale distally.
Subarachnoid Space: The compartment between the arachnoid and pia mater containing CSF, spinal nerves, and radicular vessels.
Total CSF Volume: ≈ 140 − 150 mL \approx 140 - 150 \text{ mL} ≈ 140 − 150 mL (with ≈ 30 − 40 mL \approx 30 - 40 \text{ mL} ≈ 30 − 40 mL occupying the spinal subarachnoid space).
CSF Production Rate: ≈ 0.35 − 0.50 mL/min ≈ 20 − 25 mL/hr ≈ 500 mL/day \approx 0.35 - 0.50 \text{ mL/min} \approx 20 - 25 \text{ mL/hr} \approx 500 \text{ mL/day} ≈ 0.35 − 0.50 mL/min ≈ 20 − 25 mL/hr ≈ 500 mL/day by the choroid plexuses in the cerebral ventricles.
CSF Specific Gravity / Density: 1.0003 − 1.0008 g/mL 1.0003 - 1.0008 \text{ g/mL} 1.0003 − 1.0008 g/mL (mean 1.0006 g/mL 1.0006 \text{ g/mL} 1.0006 g/mL at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ).
CSF Pressure: 10 − 20 cmH 2 O 10 - 20 \text{ cmH}_2\text{O} 10 − 20 cmH 2 O in the lateral decubitus position ( 20 − 30 cmH 2 O 20 - 30 \text{ cmH}_2\text{O} 20 − 30 cmH 2 O sitting).
2. Needle Trajectories: Midline vs. Paramedian Approaches [MIDLINE vs PARAMEDIAN NEEDLE PATHWAY]
- MIDLINE APPROACH PARAMEDIAN APPROACH
- ================ ===================
- [1. Skin] [1. Skin]
- |\ |
- [2. Subcutaneous Fat] [2. Subcutaneous Fat]
- |\ |
- [3. Supraspinous Ligament] [3. Paraspinal Muscle / Fascia]
- |\ | (Bypasses Supraspinous
- [4. Interspinous Ligament] | & Interspinous Ligaments)
- |\ |
- +-------------------+---------------------+
- |
- v
- [5. LIGAMENTUM FLAVUM] (Crisp "pop" / resistance change)
- |
- v
- [6. Epidural Space] (Negative pressure space)
- |
- v
- [7. Dura Mater] (Fibroelastic barrier)
- |
- v
- [8. Arachnoid Mater] (Final "pop" into CSF)
- |
- v
>>> SUBARACHNOID SPACE <<< (Free flow of clear CSF) +-------------------------------------------------------------------------+
- | MIDLINE vs. PARAMEDIAN APPROACH COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Feature | Midline Approach | Paramedian Approach |
- +--------------------+------------------------+---------------------------+
- | **Entry Point** | Midpoint between | 1.0 - 1.5 cm lateral and |
- | | adjacent spinous procs | 1.0 cm inferior to spine |
- | **Needle Angle** | Perpendicular / slight | 10° - 15° cephalad and |
- | | cephalad tilt (10°-15°)| 10° - 15° medial tilt |
- | **Ligaments | • Supraspinous | • Ligamentum Flavum ONLY |
- | Traversed** | • Interspinous | (Bypasses supraspinous |
- | | • Ligamentum Flavum | and interspinous) |
- | **Primary | Standard anatomy with | • Severe lumbar lordosis |
- | Indications** | good spine flexion | • Calcified ligaments |
- | | | • Inability to flex spine |
- | | | • Ankylosing spondylitis |
- | | | • Prior lumbar fusion |
- +--------------------+------------------------+---------------------------+
- Spinal Needle Design
Cutting Needles (Quincke-Babcock): Sharp, beveled cutting tip that transects longitudinal dural elastic fibers. Associated with higher rates of Post-Dural Puncture Headache (PDPH).
Pencil-Point / Non-Cutting Needles (Whitacre, Sprotte, Pencan): Rounded, non-cutting tip with a lateral injection orifice. Spreads and separates longitudinal dural fibers rather than cutting them, dramatically lowering PDPH rates ( < 1 % <1\% < 1% vs 10 − 30 % 10-30\% 10 − 30% with cutting needles).
3. Local Anesthetic Baricity & Spread Kinetics
Baricity is the ratio of local anesthetic density to human CSF density at body temperature ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ): Baricity = Density of Local Anesthetic (at 37 ∘ C) Density of CSF (at 37 ∘ C) \text{Baricity} = \frac{\text{Density of Local Anesthetic (at } 37^\circ\text{C)}}{\text{Density of CSF (at } 37^\circ\text{C)}} Baricity = Density of CSF (at 3 7 ∘ C) Density of Local Anesthetic (at 3 7 ∘ C) +-------------------------------------------------------------------------+
- | LOCAL ANESTHETIC BARICITY MATRIX |
- +--------------------+------------------+----------------+----------------+
- | Baricity Class | Density (g/mL) | Additive Agent | Spread Dynamics|
- +--------------------+------------------+----------------+----------------+
- | **Hyperbaric** | **> 1.0015** | **5% - 8.25%** | Sinks to the |
- | (e.g., 0.75% | (Heavier than | **Dextrose** | lowest point of|
- | Bupivacaine in Dex)| CSF) | | gravitational |
- | | | | dependence |
- | **Isobaric** | **0.9990 - | **0.9% Normal | Remains at the |
- | (e.g., 0.5% Plain | 1.0015** | Saline** | level of |
- | Bupivacaine) | (Equal to CSF) | | injection; not |
- | | | | position-driven|
- | **Hypobaric** | **< 0.9990** | **Sterile | Floats UPWARDS |
- | (e.g., 0.2% Plain | (Lighter than | Water** | against gravity|
- | Tetracaine in H₂O) | CSF) | | to nondependent|
- | | | | anatomical zones|
+--------------------+------------------+----------------+----------------+ [SPINAL CANAL GRAVITATIONAL CURVATURES]
- Cervical Lordosis Thoracic Kyphosis Lumbar Lordosis Sacral Hollow
- (C5) (T4) (L3) (S2)
- /\ \ /\ \
- / \ \ / \ \
- / \ \ / \ \-----
- / \ \------------------/ \ /
- Cephalad Lowest Point (T4) Highest Point (L3) Caudad
- Clinical Manipulations of Baricity and Position
Hyperbaric Solutions in Supine Position: Hyperbaric local anesthetic injected at L3-L4 flows down the lumbar lordotic incline into the dependent T4 thoracic kyphosis , naturally establishing a mid-thoracic sensory block ( T 4 − T 6 T4 - T6 T 4 − T 6 ) suitable for intra-abdominal or Cesarean surgery.
Hypobaric Solutions in Prone Jackknife Position: Hypobaric tetracaine or bupivacaine floats cephalad toward the nondependent sacral nerve roots, producing dense perineal/perianal anesthesia without spreading to thoracic sympathetic fibers (ideal for anorectal surgery).
Unilateral "Hemi-Spinal" Anesthesia: Hyperbaric drug administered to a patient maintained in the lateral decubitus position for 15 − 20 minutes 15 - 20 \text{ minutes} 15 − 20 minutes pools exclusively in the dependent operative limb.
Primary Determinants of Spinal Block Height
Major Factors: Baricity of solution, patient positioning during and immediately after injection (first 15 − 20 minutes 15 - 20 \text{ minutes} 15 − 20 minutes before fixation), total drug dose (mass in milligrams), and site of injection.
Lumbosacral CSF Volume: Inversely proportional to block height. Conditions that compress the subarachnoid space (e.g., morbid obesity, increased intra-abdominal pressure, pregnancy with engorged epidural veins) decrease spinal CSF volume, leading to higher, more extensive cephalad spread for a given drug dose.
Negligible / Minor Factors: Injection speed (minor effect), barbotage (no significant clinical difference), patient weight, coughing/straining after injection.
4. Differential Blockade & Systemic Physiological Effects
Local anesthetics block nerve fibers based on axonal diameter, degree of myelination, and conduction velocity: +-------------------------------------------------------------------------+
- | DIFFERENTIAL NEURAXIAL BLOCK HIERARCHY |
- +--------------------+-----------------------+----------------------------+
- | Fiber Class | Functional Modality | Relative Dermatomal Level |
- +--------------------+-----------------------+----------------------------+
- | **B Fibers** | Preganglionic | **2 to 6 Dermatomes HIGHER |
- | (Small myelinated) | Sympathetic Vasomotor | than Sensory Block** |
- | **A-δ and C Fibers**| Pain, Temperature, | **Baseline Sensory Block |
- | (Small un-/myel.) | Sharp Prick | Level** (e.g., T4 Nipple) |
- | **A-α and A-β** | Motor Function, Touch,| **2 Dermatomes LOWER |
- | (Large myelinated) | Deep Pressure | than Sensory Block** |
+--------------------+-----------------------+----------------------------+ [DERMATOME BLOCK HIERARCHY ILLUSTRATION]
- Dermatome Level
- T1-T2 ----------------- [SYMPATHETIC BLOCK] (2 to 6 segments above sensory)
- |
- |
- T4 ================= [SENSORY BLOCK] (Cold / Pinprick Loss: Nipple Level)
- |
- |
- T6 ----------------- [MOTOR BLOCK] (2 segments below sensory)
- Cardiovascular System & The Bezold-Jarisch Reflex
Neuraxial sympathectomy causes extensive arteriolar and venous dilation:
Venodilation & Preload Reduction: Venous capacitance vessels dilate, sequestering blood in the splanchnic circulation and lower extremities. Central venous pressure (CVP), venous return, and stroke volume decline rapidly.
Cardioaccelerator Blockade ( T 1 − T 4 T1 - T4 T 1 − T 4 ): Sympathetic fibers originating from the T1 to T4 spinal segments innervate the sinoatrial (SA) node, atrioventricular (AV) node, and ventricular myocardium. Loss of cardiac accelerator tone results in unopposed parasympathetic (vagal) activity, precipitating profound bradycardia and impaired inotropy.
The Bezold-Jarisch Reflex (BJR):
Trigger: Acute, severe reduction in left ventricular filling volume (underfilled, empty ventricle).
Pathway: Intramyocardial mechanoreceptors (unmyelinated C-fibers) in the inferoposterior wall of the left ventricle are stimulated by vigorous contraction around an empty chamber.
Efferent Response: Massive vagal parasympathetic discharge triggering the lethal triad of profound bradycardia, hypotension, and peripheral vasodilation (which can progress to asystole). [BEZOLD-JARISCH REFLEX (BJR) MECHANISM]
- Neuraxial Sympathectomy (Venodilation + Splanchnic Pooling)
- |
- v
- Severe Drop in Venous Return
- |
- v
- Empty / Underfilled Hypercontractile Left Ventricle
- |
- v
- Activation of Ventricular Mechanoreceptors (Intramyocardial C-Fibers)
- |
- v
- Vagal Afferent Signals to Brainstem (NTS)
- |
- v
- Massive Parasympathetic (Vagal) Efferent Surge
- |
- +--------------------------+--------------------------+
- | |
- v v
- Profound Bradycardia / Sinus Arrest Profound Vasodilation / Collapse
- Respiratory System Consequences
Diaphragmatic Innervation: The diaphragm is innervated by the phrenic nerve ( C 3 , C 4 , C 5 C3, C4, C5 C 3 , C 4 , C 5 ) . High thoracic spinals ( T 1 − T 4 T1 - T4 T 1 − T 4 ) leave resting tidal volume and diaphragmatic excursion intact.
Intercostal & Abdominal Paralysis: High thoracic blocks paralyze intercostal muscles ( T 1 − T 11 T1 - T11 T 1 − T 11 ) and abdominal wall expiratory muscles ( T 6 − L 1 T6 - L1 T 6 − L 1 ). This impairs forced vital capacity (FVC) , active exhalation, and the ability to generate a forceful cough, leading to subjective complaints of dyspnea despite normal arterial blood gas oxygenation.
Gastrointestinal, Renal & Endocrine Systems
Gastrointestinal: Unopposed vagal parasympathetic innervation ( T 5 − L 1 T5 - L1 T 5 − L 1 sympathetic inhibition) produces a small, contracted, hyperperistaltic bowel with relaxed sphincters, facilitating surgical exposure.
Renal: Renal blood flow is maintained through autoregulation until mean arterial pressure drops below 50 − 60 mmHg 50 - 60 \text{ mmHg} 50 − 60 mmHg . S2-S4 block paralyzes the bladder detrusor muscle, causing urinary retention.
Endocrine / Stress Response: Complete somatic and autonomic afferent neural blockade profoundly suppresses the surgical neuroendocrine stress response (inhibiting intraoperative surges of cortisol, catecholamines, renin, and ACTH).
5. High Spinal vs. Total Spinal Anesthesia: Crisis Management +-------------------------------------------------------------------------+
- | HIGH SPINAL vs. TOTAL SPINAL COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Characteristic | High Spinal | Total Spinal |
- +--------------------+------------------------+---------------------------+
- | **Block Level** | Mid-to-high cervical | Intracranial / Brainstem |
- | | dermatomes (C3 - C8) | spread of local anesthetic|
- | **Consciousness** | Conscious, alert, | Rapid loss of conscious- |
- | | highly anxious | ness; unresponsiveness |
- | **Pupils** | Normal reactivity | Bilateral fixed, dilated |
- | **Respiration** | Dyspnea, weak cough, | Complete apnea (phrenic + |
- | | intact diaphragm (C3-5)| medullary arrest) |
- | **Upper Extremity**| Finger tingling (C8), | Complete flaccid quadri- |
- | | weak hand grip (C7-T1) | plegia; aphonia |
- | **Hemodynamics** | Severe bradycardia, | Severe cardiovascular |
- | | profound hypotension | collapse, asystole |
+--------------------+------------------------+---------------------------+ +-------------------------------------------------------------------------+
- | TOTAL SPINAL EMERGENCY RESUSCITATION PROTOCOL |
- +-------------------------------------------------------------------------+
- | |
- | 1. AIRWAY & OXYGENATION (Immediate Priority) |
- | • Call for immediate assistance / code cart |
- | • Administer 100% FiO₂ via bag-mask ventilation |
- | • Perform immediate endotracheal intubation with cuffed ETT |
- | |
- | 2. CIRCULATORY RESUSCITATION & VOLUME LOADING |
- | • Rapid IV crystalloid / colloid infusion (1000 - 2000 mL bolus) |
- | • Elevate lower extremities to autotransfuse pooled venous volume |
- | • DO NOT place in steep Trendelenburg immediately if hyperbaric drug |
- | was just given (<15 min), to prevent further cephalad migration; |
- | once fixed (>20 min), Trendelenburg aids cerebral perfusion |
- | |
- | 3. PHARMACOLOGIC HEMODYNAMIC SUPPORT |
- | • Mild/Moderate Hypotension with Normal HR: Phenylephrine 50-100 mcg IV|
- | • Moderate Hypotension with Bradycardia: Ephedrine 5 - 10 mg IV |
- | • Severe Bradycardia / Refractory Hypotension: EPINEPHRINE |
- | - Bolus: 10 - 100 mcg IV (0.01 - 0.1 mg) |
- | - Continuous Infusion: 0.05 - 0.2 mcg/kg/min |
- | • Severe Vagal Bradycardia: Atropine 0.5 - 1.0 mg IV or Glycopyrrolate|
- | |
- | 4. DURATION & POST-RESUSCITATION CARE |
- | • Maintain mechanical ventilation and sedation until block regresses |
- | • Block regression typically occurs over 1 - 3 hours |
- +-------------------------------------------------------------------------+
6. Neurological Complications: Cauda Equina Syndrome vs. TNS +-------------------------------------------------------------------------+
- | CAUDA EQUINA SYNDROME (CES) vs. TNS COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Diagnostic Domain | Cauda Equina Syndrome | Transient Neurologic |
- | | (CES) | Symptoms (TNS) |
- +--------------------+------------------------+---------------------------+
- | **Etiology** | Direct neurotoxic | Non-structural myofascial/|
- | | injury / axonal necrosis| radicular inflammation |
- | **Historical Risk | 5% Hyperbaric Lidocaine| • Lidocaine (30% - 40%) |
- | Factors** | via continuous spinal | • Lithotomy position |
- | | microcatheters (28-32G)| • Outpatient knee arthrosc|
- | **Onset Time** | Immediate upon block | 12 - 24 hours post-block |
- | | resolution | (after complete recovery) |
- | **Clinical Signs** | • **Loss of bowel and | • Severe aching / burning |
- | | bladder control** | pain in buttocks/thighs |
- | | • **Saddle anesthesia**| • **NO MOTOR DEFICIT** |
- | | (S2 - S5 dermatomes) | • **NO SENSORY LOSS** |
- | | • Lower extremity | • **NORMAL REFLEXES** |
- | | paraplegia / weakness| • **NORMAL BOWEL/BLADDER**|
- | **Prognosis** | Often permanent / slow,| Complete spontaneous |
- | | incomplete recovery | resolution in 1 - 7 days |
- | **Treatment** | Urgent neurosurgical | NSAIDs, acetaminophen, |
- | | evaluation; supportive | heat packs, gabapentin |
- +--------------------+------------------------+---------------------------+
NCE Board Trap — Local Anesthetic Selection for TNS: The incidence of Transient Neurologic Symptoms (TNS) is highest with lidocaine (regardless of concentration: 5%, 2%, or 0.5%) and mepivacaine, especially when paired with lithotomy positioning or knee arthroscopy. Diluting lidocaine does NOT eliminate TNS. The incidence is lowest with bupivacaine (<1%) , ropivacaine, and 2-chloroprocaine.